Introduction {#Sec1}
============

*Staphylococcus aureus* is a major pathogen responsible for numerous diseases from minor skin infection to septicemia, affecting humans and other animals. Its name "*aureus*" comes from the golden color of strains that express carotenoid pigments \[[@CR1]\]. These pigments contribute to oxidative stress and neutrophil resistance, and virulence \[[@CR2]\]. The carotenoid biosynthetic operon (*crtMNOPQ*) leading to the synthesis of staphyloxanthin is regulated by σ^B^ \[[@CR3], [@CR4]\], an alternative σ factor that also controls a large number of general stress genes. σ^B^ activity depends on RsbU, its positive regulator \[[@CR5], [@CR6]\]. Numerous strains, including the *S. aureus* model NCTC8325, have *rsbU* mutations that prevent σ^B^ activity and *crt* operon expression, such that colonies are white. In addition, mutations in 37 genes were shown to result in the loss of a yellow pigmentation \[[@CR5], [@CR7]\].

Hfq is an RNA chaperone needed for activity of numerous regulatory RNAs in Gram-negative bacteria \[[@CR8]\]. However, its role in Gram-positive bacteria, with the exception of *Clostridium difficile* \[[@CR9]\], remains enigmatic \[[@CR10]\]. Hfq functionality from different species is often tested by interspecies complementation tests. However, expression of *hfq* genes from Gram-positive bacteria *S. aureus* and *Bacillus subtilis* in *Salmonella* could not compensate the absence of endogenous *hfq*, indicating a functional difference between Gram positive and negative Hfq \[[@CR11], [@CR12]\].

We previously compared phenotypes of *S. aureus hfq* mutants with their isogenic parental strains and observed no detectable difference associated with the absence of Hfq in the tested conditions \[[@CR13]\]. However, our results were partly challenged by a publication reporting that carotenoid pigment production was increased in *hfq*-negative strains \[[@CR14]\]. Here we use nine different *S. aureus* strains to show that Hfq absence or overexpression has no effect on pigment expression.
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### Bacterial strains, plasmids and growth conditions {#Sec4}

Bacterial strains, plasmids and primers used in this study are listed in Table [1](#Tab1){ref-type="table"}. Allelic replacements of *hfq*^+^ by Δ*hfq*::cat were either performed by ϕ11-phage mediated transduction using RN4220 *hfq*::cat as a donor strain or by homologous recombination using pMADΔhfq::cat \[[@CR13], [@CR15]\]. The Δ*hfq*::*cat* deletion in SAPHB5 was verified by Southern blot and subsequent Δ*hfq*::*cat* transductants were verified by PCR as described \[[@CR13]\].Table 1*Staphylococcus aureus* strains, plasmids and primer used for this studyStrain nameKey featuresReference or constructionRN4220Transformable by DNA from *E. coli*\[[@CR25]\]SAPhB5RN4220 Δ*hfq*::*cat*\[[@CR13]\]NCTC8325Clinical isolate\[[@CR26]\]SAPhB224NCTC8325 Δ*hfq*::*cat*NCTC8325 + ϕ11(SAPhB5)NCTC8325-4NCTC8325 Δϕ11 Δϕ12 Δϕ13\[[@CR27]\]SAPhB197NCTC8325-4 Δ*hfq*::*cat*NCTC8325-4 + ϕ11(SAPhB5)RN6390NCTC 8325-4 ϕ6390\[[@CR28]\]SAPhB22RN6390 Δ*hfq*::*cat*\[[@CR13]\]HG001NCTC8325 *rsbU* repaired\[[@CR22]\]SAPhB199HG001 Δ*hfq*::*cat*HG001 + ϕ11(SAPhB5)HG002NCTC8325 *tcaR* repaired\[[@CR22]\]SAPhB201HG002 Δ*hfq*::*cat*HG002 + ϕ11(SAPhB5)HG003NCTC8325 *rsbU* and *tcaR* repaired\[[@CR22]\]SAPhB203HG003 Δ*hfq*::*cat*HG003 + ϕ11(SAPhB5)COLMethicillin resistant clinical isolate\[[@CR29]\]SAPhB16COL Δ*hfq*::*cat*\[[@CR13]\]NewmanClinical isolate\[[@CR30]\]SAPhB17Newman Δ*hfq*::*cat*\[[@CR13]\]SAPhB142RN4220 pRMC2RN4220 + pRMC2SAPhB248RN4220 pRMC2HfqRN4220 + pRMC2HfqSAPhB251RN4220 pRMC2HfqFLAGRN4220 + pRMC2HfqFLAGSAPhB233HG003 pRMC2HG003 + pRMC2SAPhB249HG003 pRMC2HfqHG003 + pRMC2HfqSAPhB257HG003 pRMC2HfqFLAGHG003 + pRMC2HfqFLAGPlasmid nameKey featuresReference/constructionpRMC2Anhydrotetracycline (aTc) inducible promoter P~xyl/tetO~\[[@CR17]\]pRMC2Hfq*hfq* inducible expressionSee "[Methods](#Sec3){ref-type="sec"}"pRMC2FLAGpRMC2 derivative for translational gene fusions with *3xflag* coding sequenceSee "[Methods](#Sec3){ref-type="sec"}"pRMC2HfqFLAG*hfq::3xflag* inducible expressionSee "[Methods](#Sec3){ref-type="sec"}"Primer nameSequencePurpose39GGGGTACCATGATTGCAAACGAAAAC*hfq* amplification (with a KpnI site)49GGGGAATTCTTATTCTTCACTTTCAGTAGATGC*hfq* amplification (with an EcoRI site)856GGTACCGTTAACAGATCTGAGpRMC2 amplification918GCTTATTTTAATTATACTCTATCAATGATAGAGpRMC2 and pRMC2FLAG amplifications858TCAGATCTGTTAACGGTACCGGAATTAGCTTGCATGGAA*3xflag* amplification919GATAGAGTATAATTAAAATAAGCGAGCTCGACTACAAAGACCA*3xflag* amplification865GACTACAAAGACCATGACGGpRMC2FLAG amplification939GATAGAGTATAATTAAAATAAGCGTAAAAGGAGTCCGACAGATGA*hfq* amplification for cloning in pRMC2FLAG940CCGTCATGGTCTTTGTAGTCTTCTTCACTTTCAGTAGATGCTTG*hfq* amplification for cloning in pRMC2FLAG

Engineered plasmids were constructed as described \[[@CR16]\]. Conditional *hfq* expression was obtained by cloning *hfq* under the xyl/tetO promoter in pRMC2 \[[@CR17]\] and pRMC2FLAG (Table [1](#Tab1){ref-type="table"}). pRMC2Hfq allowing *hfq* conditional expression was obtained as follows: pRMC2 and PCR-amplified *hfq* (using primers 39/49 on HG003 DNA) were KpnI-EcoRI digested and ligated together. pRMC2FLAG was engineered for conditional expression of 3xFLAG-tagged proteins as followed: pRMC2 and pSUB11 \[[@CR18]\] were PCR-amplified using primers 856/918 and 858/919, respectively. The two resulting products, i.e. pRMC2 and *3xflag* coding sequence, were assembled using the Gibson method \[[@CR19]\]. pRMC2HfqFLAG, allowing conditional expression of Hfq::3xFLAG, was obtained as follows: pRMC2FLAG and *hfq* HG003 were PCR-amplified using primers 918/865 and 939/940, respectively. The two resulting products were assembled using the Gibson method.

Bacteria were grown in BHI medium (BD Difco, ref: 237500) at 37 °C under vigorous agitation. BHI solid media were obtained by the addition of Bacto Agar 15 g l^−1^ (BD Difco, ref: 214010). For strains containing pRMC2 and derivatives, chloramphenicol (Sigma-Aldrich, ref: C0378) 5 µg ml^−1^ was added to media. Expression from pRMC2 and derivatives was achieved by anhydrotetracycline (aTc, Chemodex, ref: CDX-A0197-M500) 250 ng ml^−1^ addition to growth media.

### Protein extraction, Western blotting and staphyloxanthin spectral measurement {#Sec5}

Overnight cultures were diluted 1000 times in fresh medium. After 3 h, aTc was added. 10 min and 30 min later, cells were harvested by centrifugation (16,000*g* for 2 min), resuspended in 400 µl Tris HCl buffer (50 mM, pH 6.8) and lysed using a FastPrep (3 cycles of 45 s at 6.5 m s^−1^). Cell debris was removed by centrifugation (16,000*g* for 10 min). Protein concentration was determined by Bradford assays \[[@CR20]\]. For each sample, 3 μg of protein extract was separated on a polyacrylamide gel (Blot™ 4--12% Bis--Tris Plus, Invitrogen, ref: NW04122BOX). After electrophoresis, proteins were transferred to a polyvinylidene fluoride membrane (iBlot 2 PVDF Mini Stacks, Invitrogen ref: IB24002). For blotting and washing, an iBind™ Flex Western System (ref: SLF2000S) was used according to supplier's instructions. Membranes were probed with the primary polyclonal ANTI-FLAG antibody produced in rabbit (Sigma, ref: F-7425) at a 1/15,000 dilution. A rabbit secondary antibody conjugated to horseradish peroxidase (Advansta, ref: R-05072-500) was used at a 1/25,000 dilution. Bioluminescent signal was detected with the WesternBright™ ECL-spray (Advansta, ref: K-12040-D50) using a digital camera (ImageQuant™ 350, GE Healthcare).

The *S. aureus* pigments were extracted as described \[[@CR21]\]. In brief, strains were grown in BHI under vigorous agitation for 24 h. Cells were harvested by centrifugation, the pellet was rinsed twice with sterile water and pigments were extracted by methanol. Absorbance between 330 and 550 nm was measured on a microplate reader (CLARIOstar BMG LABTECH).

Results {#Sec6}
-------

### The absence of Hfq does not alter *S. aureus* pigmentation {#Sec7}

In 2010, Liu et al. reported that "deletion of *hfq* gene in *S. aureus* 8325-4 can increase the surface carotenoid pigments" \[[@CR14]\]. Their work was performed using an allele called *Δhfq*-*8325* in which the *hfq* coding sequence was replaced by a kanamycin cassette. The *hfq* chromosomal deletion was constructed in strain RN4220 and then transduced into NCTC8325-4, RN6390, COL and ATCC25923 by phage ϕ11. We constructed a similar *hfq* deletion in RN4220, except that the *hfq* coding sequence was replaced by a chloramphenicol resistant gene (Δ*hfq*::cat); this allele was transduced into RN6390, COL and Newman by ϕ11-phage mediated transduction \[[@CR13]\]. Note that RN4220, RN6390 and COL strains were used for both studies. As we did not notice a change of color when the Δ*hfq*::cat allele was introduced into these strains, this information was not reported \[[@CR13]\]. In view of the previous report, we focused this work on the possibility that Hfq could affect *S. aureus* pigment expression.

NCTC8325 isolated in 1960 from a sepsis patient is the progenitor of numerous strains including NCTC8325-4 (cured of three prophages) which itself gave RN6390 and RN4220 \[[@CR22]\]. As these descendants were mutagenized, they carry several mutations that may affect their phenotypes. NCTC8325 has a deletion of 11 bp in *rsbU* and a point mutation in *tcaR*. The derivatives HG001 (*rsbU* restored), HG002 (*tcaR* restored), HG003 (*rsbU* and *tcaR* restored) were constructed to perform physiological studies in a non-mutagenized background \[[@CR22]\]. All these NCTC8325 derived strains, except HG001 and HG003 (which have a functional σ^B^ factor), give rise to white colonies (Fig. [1](#Fig1){ref-type="fig"}). In addition to those reported \[[@CR13]\], we constructed Δ*hfq*::cat derivatives in NCTC8325, NCTC8325-4, HG001, HG002 and HG003 (Table [1](#Tab1){ref-type="table"}). In contrast to results reported in Liu et al., deletion of the *hfq* gene in all tested strain backgrounds had no effect on pigmentation (Fig. [1](#Fig1){ref-type="fig"}a). Note that COL, Newman are not NCTC8325 derivatives.Fig. 1Absence of Hfq does not affect *S. aureus* pigmentation. The indicated strains were grown overnight in BHI and then **a** streaked on BHI agar or **b** assayed for spectral profiles as described \[[@CR21]\]

Spectral profiles highlighting *S. aureus* carotenoid production were determined as described \[[@CR21]\] for three strains and their *hfq* derivatives after growth for 24 h in BHI. HG003 and HG003 Δ*hfq*::*cat* gave equivalent profiles with three pics characteristic of carotenoid production. In contrast, NCTC8325-4 and RN1 had spectra characteristic of no or very little carotenoid production. As expected from our visual observation (Fig. [1](#Fig1){ref-type="fig"}a), the spectra of Δ*hfq* derivatives did not differ from those of their respective parental strains (Fig. [1](#Fig1){ref-type="fig"}b).

### Hfq overexpression does not alter *S. aureus* pigmentation {#Sec8}

In the above-described strains, *hfq* is possibly poorly expressed, in which case *hfq* deletions would not lead to detectable phenotypes. We therefore tested the effects of an inducible Hfq expression system on pigment production. If the absence of Hfq leads to yellow colonies as proposed \[[@CR14]\], the presence of Hfq could lower pigment production and lead to white colonies. To address this point, *hfq* was cloned under the control of the P~xyl/tetO~ promoter in multi-copy plasmid pRMC2 \[[@CR17]\] leading to pRMC2Hfq. *hfq* expression in strains harboring pRMC2Hfq was induced upon aTc addition to media. To confirm that P~xyl/tetO~ was effectively driving *hfq* expression, a pRMC2Hfq derivative was engineered harboring a *3xflag* sequence inserted in frame at the end of the *hfq* open reading frame. The resulting plasmid, pRMC2HfqFLAG is a proxy for expression from pRMC2Hfq. HG003 was transformed with pRMC2, pRMC2Hfq and pRMC2HfqFLAG. The protein Hfq::3xFLAG was detected upon aTc induction by western blotting using FLAG antibodies (Fig. [2](#Fig2){ref-type="fig"}a). We inferred from this result that addition of aTc to strains harboring pRMC2Hfq lead to Hfq synthesis. The RN4220 white and HG003 yellow colors were not affected by the presence of either pRMC2, pRMC2Hfq or pRMC2HfqFLAG and remained identical upon aTc addition to growth medium (Fig. [2](#Fig2){ref-type="fig"}b).Fig. 2Accumulation of Hfq does not affect *S. aureus* pigmentation. The indicated strains were grown in BHI supplemented with chloramphenicol. They were then **a** assayed by Western blotting for *hfq*::*3xflag* expression (see "[Methods](#Sec3){ref-type="sec"}") and **b** streaked on BHI agar supplemented with aTc when indicated

Conclusion {#Sec9}
----------

Our results show that neither the absence, nor the accumulation of Hfq affects pigmentation of *S. aureus*: Hfq does not appear to regulate staphyloxanthin synthesis. Our conclusions are supported by Tarrant PhD dissertation showing an NCTC8325 *hfq* mutant that remained unpigmented \[[@CR23]\]. Of note, *Pseudomonas aeruginosa* reportedly induces pigment production of a non-pigmented phenotypic variant of *S. aureus*, however, this effect was independent of *hfq* transcription \[[@CR24]\]. In addition, color variation in USA300 strain was screened in a genome-wide transposon mutant library, and the *hfq* inactivation was not reported to affect *S. aureus* pigmentation \[[@CR7]\].

While the *hfq* gene is absent in some Firmicutes (e.g. Lactobacillales), it is conserved in all *S. aureus*, suggesting that it plays a crucial function, however not related to pigment expression. The quest to find the Staphylococcal Hfq function remains open.

Limitations {#Sec10}
===========

Our conclusion is in contradiction with Liu et al. results concerning the effect of Hfq on *S. aureus* pigmentation \[[@CR14]\]. We cannot rule out that our observation is limited to specific *S. aureus* strains. However, we used an NCTC8325-4 *hfq* derivative similar the one used in the previous study. Furthermore, the present results are strengthened by the construction of *hfq* mutants in numerous *S. aureus* backgrounds. The discrepancy between our and Liu et al. 2010 \[[@CR14]\] results, is a possible inadvertent selection of mutants with altered color patterns (as shown in \[[@CR23]\]) in the former study.
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